Flagium AI
🔍Search stocks...
PortfolioWatchlistAsk SentinelRisk RadarRisk Explorer
Earnings Terminal/EXPLEOSOL

Expleo Solutions

EXPLEOSOL

Information Technology

Quarterly structural health evolution — tracking what changed beneath the surface across each reporting period.

Quarterly History

Q2-FY27 | 30 Sep 26Latest
🟠 Watch

🚨 Structural Deterioration Signature: In Q2 FY2027, Expleo Solutions reported a 2.4% YoY revenue growth to ₹302.6 Cr, but net profit contracted by 8.5% to ₹36.4 Cr, with EBITDA margins compressing by 3.4 pp to 16.7%. This deterioration persists across interim quarters since FY2026, with Q1 FY2027 showing 12.0% revenue growth and Q2 FY2027 confirming a 2.4% YoY revenue expansion, though net profit remained under sector median performance. The operational strain is compounded by elevated governan

Risk34▲18
Q1-FY27 | 30 Jun 26
🟢 Stable

Expleo Solutions posted steady top-line growth and bottom-line stability, demonstrating resilient execution in its core markets. While the underlying business remains fundamentally sound, the presence of 1 active risk warnings highlights minor operational or working capital inefficiencies to keep on the watch list.

Risk16▲8
Disclaimer: Flagium AI is an automated financial data analytics platform. Analysis reports do not constitute investment advice.
© 2026 Flagium AI
PrivacyTermsRefund PolicyDisclaimer
Flagium AI is a technology platform providing automated financial data analytics for informational and educational purposes only. It is not registered with SEBI as an Investment Adviser or Research Analyst and does not provide investment advice or recommendations. Investments in securities market are subject to market risks. Read all the related documents carefully before investing.